Item 5. OTHER INFORMATION

2K characters. Original on sec.gov · Markdown

Item 5. OTHER INFORMATION

Trading Arrangements

During the three months ended March 31, 2026, the Company’s directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted, materially modified or terminated written plans intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c) for the sale of the Company’s securities as set forth in the table below.


Name	Position	Action	Date	Total Shares of Class A Common Stock to be Sold	Expiration Date

David Galloreese	Chief People Officer	Adoption	March 6, 2026	10,210	May 28, 2027
David Obstler(1)	Chief Financial Officer	Modification	March 9, 2026	75,000	March 31, 2027
Amit Agarwal(2)	Director	Adoption	March 13, 2026	200,000	March 25, 2027
Michael Callahan(3)	Director	Adoption	March 13, 2026	175,000	March 12, 2027
(1) Represents a modification under Rule 10b5-1(c)(1)(iv) of a Rule 10b5-1 trading plan adopted on December 14, 2025, which did not result in any change to the total number of shares to be sold under or the expiration date of the plan.
(2) The shares will be sold under a Rule 10b5-1 trading plan by the Agarwal 2018 Family Trust.
(3) The shares will be sold under a Rule 10b5-1 trading plan by The Callahan-Thernstrom Family Trust.

Previous: Item 1A. RISK FACTORS · Next: Item 6. EXHIBITS